Antoine Rosier

975 total citations
10 papers, 266 citations indexed

About

Antoine Rosier is a scholar working on Cognitive Neuroscience, Genetics and Psychiatry and Mental health. According to data from OpenAlex, Antoine Rosier has authored 10 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cognitive Neuroscience, 6 papers in Genetics and 6 papers in Psychiatry and Mental health. Recurrent topics in Antoine Rosier's work include Autism Spectrum Disorder Research (7 papers), Genetics and Neurodevelopmental Disorders (6 papers) and Attention Deficit Hyperactivity Disorder (4 papers). Antoine Rosier is often cited by papers focused on Autism Spectrum Disorder Research (7 papers), Genetics and Neurodevelopmental Disorders (6 papers) and Attention Deficit Hyperactivity Disorder (4 papers). Antoine Rosier collaborates with scholars based in France, Portugal and Spain. Antoine Rosier's co-authors include Olivier Guillin, Jean‐Michel Roué, Sylvie Serret, Marine Viellard, Delphine Bernoux, Sandrine Sonié, Nathalie Villeneuve, Susanne Thümmler, P. Brosset and Éric Lemonnier and has published in prestigious journals such as Journal of Autism and Developmental Disorders, Translational Psychiatry and Journal of Clinical Psychopharmacology.

In The Last Decade

Antoine Rosier

9 papers receiving 259 citations

Peers

Antoine Rosier

CN

PMH

GENET

CMN

MB

Glynis Ivin United Kingdom

Vesna Bryn Norway

Laura Ajram United Kingdom

Céline Degrez France

M.F. Gosso Netherlands

Martin Heasman United Kingdom

Claudio Paloscia Italy

Marine Viellard France

Djenifer B. Kappel Brazil

Thomas A. Avino United States

Glynis Ivin United Kingdom

Antoine Rosier

191 ×1.1

CN

109 ×0.8

PMH

85 ×0.9

GENET

99 ×1.6

CMN

30 ×0.7

MB

Citations per year, relative to Antoine Rosier Antoine Rosier (= 1×) peers Glynis Ivin

Countries citing papers authored by Antoine Rosier

Since Specialization

Citations

This map shows the geographic impact of Antoine Rosier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antoine Rosier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antoine Rosier more than expected).

Fields of papers citing papers by Antoine Rosier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antoine Rosier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antoine Rosier. The network helps show where Antoine Rosier may publish in the future.

Co-authorship network of co-authors of Antoine Rosier

This figure shows the co-authorship network connecting the top 25 collaborators of Antoine Rosier. A scholar is included among the top collaborators of Antoine Rosier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antoine Rosier. Antoine Rosier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Ferrín, Maite, Amaia Hervás, Stéphane Marret, et al.. (2022). A Phase III Study of Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents Aged Between 7 and 17 Years with Autism Spectrum Disorder (SIGN 1 Trial): Participant Baseline Characteristics. Child Psychiatry & Human Development. 54(5). 1360–1372. 9 indexed citations

2.

Rosier, Antoine, et al.. (2022). Développement de programmes de guidance parentale dans le champ des troubles du neurodéveloppement en Normandie orientale. Contraste. N° 56(2). 193–213.

3.

Lambert, Sylvie, Joaquín Fuentes, Antoine Rosier, et al.. (2020). Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials). Journal of Autism and Developmental Disorders. 51(8). 2959–2972. 16 indexed citations

4.

Rothärmel, Maud, et al.. (2019). A Prospective Open-Label Pilot Study of Transcranial Direct Current Stimulation in High-Functioning Autistic Patients with a Dysexecutive Syndrome. Neuropsychobiology. 78(4). 189–199. 16 indexed citations

5.

Rothärmel, Maud, et al.. (2018). Eleven Years of Clozapine Experience in Autism Spectrum Disorder. Journal of Clinical Psychopharmacology. 38(6). 577–581. 18 indexed citations

6.

Lemonnier, Éric, Nathalie Villeneuve, Sandrine Sonié, et al.. (2017). Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders. Translational Psychiatry. 7(3). e1056–e1056. 141 indexed citations

7.

Rosier, Antoine, et al.. (2013). Efficacité des traitements pharmacologiques dans les troubles envahissants du développement : une revue de la littérature. L Encéphale. 40(2). 188–196. 8 indexed citations

8.

Rosier, Antoine, et al.. (2012). Syndrome d'Asperger : les enjeux d'une disparition. 10(1). 25–33. 3 indexed citations

9.

Lambrey, Simon, et al.. (2011). Retrospective Review of Clozapine in the Treatment of Patients With Autism Spectrum Disorder and Severe Disruptive Behaviors. Journal of Clinical Psychopharmacology. 31(3). 341–344. 48 indexed citations

10.

Gillis, David, et al.. (2000). Combined 21-Hydroxylase and llß-Hydroxylase Deficiency: Patient Report and Molecular Basis. Journal of Pediatric Endocrinology and Metabolism. 13(7). 945–9. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact